Patient Safety and Advocacy Activity 2026

January 1, 2030

Activity overview here...

Target Audience

This activity is designed for an audience of...

Learning Objectives

  • Objective 1
  • Objective 2
  • Objective 3

Commercial Support
There is no commercial support for this activity.

-OR-

Commercial Support
This activity is supported from an independent medical education grant from XX.

Course summary
Available credit: 
  • 16.00 Attendance
  • 16.00 CBRN
Course opens: 
07/01/2025
Course expires: 
06/01/2030
Event starts: 
01/01/2030 - 12:00am EST
Event ends: 
01/01/2030 - 11:59pm EST
Cost:
$0.00
Rating: 
0
March 9th, 2026 in Irvine, TX
United States

Faculty/speakers here...

 

Planners and Reviewers
Dorothy Caputo, MA, BSN, RN (President, AKH Inc.)
Michele Bielarski, RN (Reviewer)
Rebecca Ann Lakofsky, BSN (Reviewer)
Dorothy Duffy, RPh (Reviewer)
Risha Bellomo PA-C (Reviewer)
Bernadette Makar, MSN, APRN-BC, NP-C (Reviewer)
Donna Purcell, Psy.D (Reviewer)
Broc Pollinger, MSW, LSW, OSW-C (Reviewer)
Deborah Cooper, RD, LDN (Reviewer)

AKH Inc Staff and Planners
 

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Allergan Medical Institute, Allergan Aesthetics an Abbvie Company AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

California Nurses
AKH Inc., Advancing Knowledge in Healthcare is a provider approved by the California Board of Registered Nursing, Provider Number CEP17011, for 16.0 contact hours.

 

Available Credit

  • 16.00 Attendance
  • 16.00 CBRN

Price

Cost:
$0.00
Please login or register to take this course.